Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.46 USD | +4.19% | +11.38% | -14.15% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.15% | 1.93B | |
-2.44% | 103B | |
+1.87% | 95.28B | |
+1.46% | 22.15B | |
-15.76% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.29% | 16.05B | |
+4.92% | 13.68B | |
+35.34% | 12.17B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals : Starts Investigational New Drug-Enabling Studies for Potential C. Difficile Treatment